Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 24, 2024
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASECecile Evin, Laurent Quéro, Karine Le Malicot, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2025
Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASEClara Naessens, Cécile Evin, Karine Le-Malicot, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 7, 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO studyElisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASEVéronique Vendrely, Claire Lemanski, Pascal Pommier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2024
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world studyJeannie M'Baloula, David Tougeron, Alice Boilève, et al.
BMC Cancer|October 12, 2023
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocolAnouchka Modesto, David Tougeron, Pierre Tremolières, et al.
International Journal of Cancer|January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter studyDavid Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
Liver Cancer|September 26, 2022
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic HepatocholangiocarcinomaElia Gigante, Christian Hobeika, Brigitte Le Bail, et al.
Bulletin Du Cancer|April 27, 2021
[Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]David Tougeron, Barbara Seitz-Polski, Maxime Hentzien, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|June 24, 2024
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASECecile Evin, Laurent Quéro, Karine Le Malicot, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2025
Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASEClara Naessens, Cécile Evin, Karine Le-Malicot, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 7, 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO studyElisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASEVéronique Vendrely, Claire Lemanski, Pascal Pommier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2024
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world studyJeannie M'Baloula, David Tougeron, Alice Boilève, et al.
BMC Cancer|October 12, 2023
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocolAnouchka Modesto, David Tougeron, Pierre Tremolières, et al.
International Journal of Cancer|January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter studyDavid Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
Liver Cancer|September 26, 2022
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic HepatocholangiocarcinomaElia Gigante, Christian Hobeika, Brigitte Le Bail, et al.
Bulletin Du Cancer|April 27, 2021
[Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]David Tougeron, Barbara Seitz-Polski, Maxime Hentzien, et al.
Pageof 24